162. 類天疱瘡（後天性表皮水疱症を含む。） Pemphigoid Clinical trials / Disease details

臨床試験数 : 90 / 薬物数 : 122 - (DrugBank : 47) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 144

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2200058412	2022-04-28	2022-04-09	A clinical study to evaluate the effectiveness and safety of Dupilumab injection (Dupixent?R) in the ...	A clinical study to evaluate the effectiveness and safety of Dupilumab injection (Dupixent?R) in the ...	Bullous Pemphigoid, BP	Experimental group:Dupilumab;	Xijing Hospital	NULL	Pending			Both	Experimental group:8;		China
2	EUCTR2019-003520-20-DE (EUCTR)	15/10/2020	26/03/2020	A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Ef ...	Bullous pemphigoid (BP) MedDRA version: 20.0;Level: PT;Classification code 10034277;Term: Pemphigoid ...	Trade Name: Dupixent Product Name: dupilumab INN or Proposed INN: dupilumab Other descriptive name: DUP ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	98	Phase 2;Phase 3	France;United States;Poland;Australia;Germany;Japan
3	EUCTR2019-003520-20-FR (EUCTR)	19/05/2020	25/03/2020	A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Ef ...	Bullous pemphigoid (BP) MedDRA version: 20.0;Level: PT;Classification code 10034277;Term: Pemphigoid ...	Trade Name: Dupixent Product Name: dupilumab INN or Proposed INN: dupilumab Other descriptive name: DUP ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80	Phase 2;Phase 3	United States;France;Spain;Australia;Germany;Japan

First Previous1Next Last